Akil Jackson

1.2k total citations
52 papers, 888 citations indexed

About

Akil Jackson is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Akil Jackson has authored 52 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 27 papers in Virology and 13 papers in Emergency Medicine. Recurrent topics in Akil Jackson's work include HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (27 papers) and HIV/AIDS Research and Interventions (17 papers). Akil Jackson is often cited by papers focused on HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (27 papers) and HIV/AIDS Research and Interventions (17 papers). Akil Jackson collaborates with scholars based in United Kingdom, United States and Norway. Akil Jackson's co-authors include Marta Boffito, David Back, Graeme Moyle, Brian Gazzard, Laura Else, Saye Khoo, Sundhiya Mandalia, Ian McGowan, Mark Nelson and Chris Higgs and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

Akil Jackson

48 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akil Jackson United Kingdom 20 686 525 228 197 79 52 888
Franco Maggiolo Italy 12 1.0k 1.5× 837 1.6× 341 1.5× 280 1.4× 135 1.7× 28 1.3k
Dan Duiculescu Romania 11 805 1.2× 628 1.2× 219 1.0× 225 1.1× 92 1.2× 22 949
Joseph J. Eron United States 16 978 1.4× 734 1.4× 297 1.3× 186 0.9× 45 0.6× 29 1.1k
Barbara Gripshover United States 15 809 1.2× 627 1.2× 413 1.8× 293 1.5× 116 1.5× 48 1.2k
Ellen Koenig United States 12 760 1.1× 533 1.0× 275 1.2× 145 0.7× 41 0.5× 23 822
Anthony T. Podany United States 18 573 0.8× 286 0.5× 135 0.6× 220 1.1× 123 1.6× 54 844
Cynthia Brinson United States 18 1.3k 2.0× 1.0k 1.9× 449 2.0× 333 1.7× 98 1.2× 36 1.5k
Elizabeth Gould United States 12 540 0.8× 387 0.7× 57 0.3× 169 0.9× 83 1.1× 15 719
Joseph Quinn United States 11 1.3k 1.9× 1.0k 2.0× 171 0.8× 351 1.8× 96 1.2× 14 1.6k
Victoria Watson United Kingdom 16 475 0.7× 398 0.8× 134 0.6× 144 0.7× 37 0.5× 32 690

Countries citing papers authored by Akil Jackson

Since Specialization
Citations

This map shows the geographic impact of Akil Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akil Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akil Jackson more than expected).

Fields of papers citing papers by Akil Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akil Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akil Jackson. The network helps show where Akil Jackson may publish in the future.

Co-authorship network of co-authors of Akil Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Akil Jackson. A scholar is included among the top collaborators of Akil Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akil Jackson. Akil Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jackson, Akil, et al.. (2024). Targeting AXL cellular networks in kidney fibrosis. Frontiers in Immunology. 15. 1446672–1446672. 1 indexed citations
3.
4.
Jackson, Akil, Laura Else, Christopher Higgs, et al.. (2017). Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals. HIV Clinical Trials. 19(1). 31–37. 4 indexed citations
5.
Jackson, Akil & Ian McGowan. (2015). Long-acting rilpivirine for HIV prevention. Current Opinion in HIV and AIDS. 10(4). 253–257. 34 indexed citations
6.
Penrose, Kerri J., Urvi M. Parikh, Constantinos G. Panousis, et al.. (2014). Selection of Rilpivirine Resistant HIV-1 in a Seroconverter on Long-acting Rilpivirine (TMC278LA) from the Lowest Dose Arm of the SSAT 040 Trial. AIDS Research and Human Retroviruses. 30(S1). A69–A69. 5 indexed citations
7.
Jackson, Akil, Antonio D’Avolio, Graeme Moyle, et al.. (2014). Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers. Journal of Antimicrobial Chemotherapy. 69(7). 1911–1915. 14 indexed citations
8.
Boffito, Marta, Akil Jackson, & David Asboe. (2014). Pharmacology Lessons From Chemoprophylaxis Studies. Clinical Infectious Diseases. 59(suppl_1). S52–S54. 4 indexed citations
9.
Jackson, Akil, Laura Else, Pedro M. M. Mesquita, et al.. (2014). A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis. Clinical Pharmacology & Therapeutics. 96(3). 314–323. 89 indexed citations
10.
Hayes, Peter, Jill Gilmour, Dilbinder K. Gill, et al.. (2013). Safety and Immunogenicity of DNA Prime and Modified Vaccinia Ankara Virus-HIV Subtype C Vaccine Boost in Healthy Adults. Clinical and Vaccine Immunology. 20(3). 397–408. 22 indexed citations
11.
Boffito, Marta, Akil Jackson, Andrew Owen, & Stephen Becker. (2013). New Approaches to Antiretroviral Drug Delivery: Challenges and Opportunities Associated with the Use of Long-Acting Injectable Agents. Drugs. 74(1). 7–13. 34 indexed citations
12.
Boffito, Marta, Julie Fox, Christine Bowman, et al.. (2013). Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial. Vaccine. 31(48). 5680–5686. 17 indexed citations
13.
Jackson, Akil, Graeme Moyle, Victoria Watson, et al.. (2012). Tenofovir, Emtricitabine Intracellular and Plasma, and Efavirenz Plasma Concentration Decay Following Drug Intake Cessation. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(3). 275–281. 39 indexed citations
14.
Westrop, Samantha J., Graeme Moyle, Akil Jackson, et al.. (2012). CCR5 Antagonism Impacts Vaccination Response and Immune Profile in HIV-1 Infection. Molecular Medicine. 18(8). 1240–1248. 20 indexed citations
15.
Else, Laura, Akil Jackson, Rebekah Puls, et al.. (2011). Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study. Antimicrobial Agents and Chemotherapy. 56(3). 1427–1433. 28 indexed citations
16.
Jackson, Akil, Victoria Watson, David Back, et al.. (2011). Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(5). 450–457. 27 indexed citations
17.
Jackson, Akil, Clotilde Allavena, F. Raffi, et al.. (2011). Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients. HIV Medicine. 12(10). 620–631. 28 indexed citations
18.
Ware, Lisa J., Akil Jackson, Stephen A. Wootton, et al.. (2009). Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men. British Journal Of Nutrition. 102(7). 1038–1046. 9 indexed citations
19.
Boffito, Marta, Alan Winston, Akil Jackson, et al.. (2007). Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance. AIDS. 21(11). 1449–1455. 57 indexed citations
20.
Jones, Rachael, Shailendra Sawleshwarkar, Christos Michailidis, et al.. (2005). Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. HIV Medicine. 6(6). 396–402. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franco Maggiolo Breakdown of academic impact, for papers by Dan Duiculescu Breakdown of academic impact, for papers by Joseph J. Eron Breakdown of academic impact, for papers by Barbara Gripshover Breakdown of academic impact, for papers by Ellen Koenig Breakdown of academic impact, for papers by Anthony T. Podany Breakdown of academic impact, for papers by Cynthia Brinson Breakdown of academic impact, for papers by Elizabeth Gould Breakdown of academic impact, for papers by Joseph Quinn Breakdown of academic impact, for papers by Victoria Watson
Rankless by CCL
2026